HISCL
Device
Sysmex America, Inc.
Total Payments
$418,784
Transactions
12
Doctors
4
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $48,302 | 1 | 0 |
| 2020 | $250,000 | 2 | 0 |
| 2019 | $82,361 | 4 | 3 |
| 2018 | $9,348 | 1 | 0 |
| 2017 | $28,772 | 4 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $418,646 | 8 | 100.0% |
| Food and Beverage | $113.37 | 2 | 0.0% |
| Gift | $24.66 | 2 | 0.0% |
Payments by Type
Research
$418,646
8 transactions
General
$138.03
4 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Development of lipoprotein function assay for cardiovascular risk evaluation | Sysmex America, Inc. | $298,302 | 0 |
| Fibrosis of Liver Study | Sysmex America, Inc. | $120,344 | 0 |
Top Doctors Receiving Payments for HISCL
Ad
Manufacturing Companies
- Sysmex America, Inc. $418,784
Product Information
- Type Device
- Total Payments $418,784
- Total Doctors 4
- Transactions 12
About HISCL
HISCL is a device associated with $418,784 in payments to 4 healthcare providers, recorded across 12 transactions in the CMS Open Payments database. The primary manufacturer is Sysmex America, Inc..
Payment data is available from 2017 to 2022. In 2022, $48,302 was paid across 1 transactions to 0 doctors.
The most common payment nature for HISCL is "Unspecified" ($418,646, 100.0% of total).
HISCL is associated with 2 research studies, including "Development of lipoprotein function assay for cardiovascular risk evaluation" ($298,302).